Thermo Scientific Pierce AMAS ist ein Amin-zu-Sulfhydryl-Crosslinker, der NHS-Ester und Maleimid-reaktive Gruppen an gegenüberliegenden Enden eines kurzen Spacerarms (4,4 Angström)Weitere Informationen
Have Questions?
Katalognummer
Menge
22295
50 mg
Katalognummer 22295
Preis (EUR)
191,00
Each
Menge:
50 mg
Großbestellung oder individuelle Größe anfordern
Preis (EUR)
191,00
Each
Thermo Scientific Pierce AMAS ist ein Amin-zu-Sulfhydryl-Crosslinker, der NHS-Ester und Maleimid-reaktive Gruppen an gegenüberliegenden Enden eines kurzen Spacerarms (4,4 Angström) enthält.
Merkmale von AMAS:
• Reaktive Gruppen:NHS-Ester und Maleimid • Reaktiv gegen: Amino- und Sulfhydrylgruppen • Kürzeste Serie aliphatischer Spacer, die AMAS, BMPS, GMBS und EMCS enthält • NHS-Ester-Endpaare mit primären Aminen bei pH 7 bis -9 enthält und stabile Amidbindungen bildet • Maleimid reagiert mit -SH-Gruppen bei einem pH-Wert von 6,5 bis 7,5, Bildung stabiler Thioether-Verbindungen • Nicht spaltbar • Wasserunlöslich (zuerst in DMF oder DMSO auflösen) • Sehr kurzer aliphatischer Spacer hat ein geringes Potenzial, eine Immunantwort zu eluieren
Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.
Specifications
ZellpermeabilitätJa
BeschreibungAMAS
FormPulver
MarkierungsmethodeChemische Markierung
Molekulargewicht252,18
PEGyliertNein
ProduktliniePierce
Menge50 mg
Reaktiver TeilMaleimid, NHS-Ester
VersandbedingungUmgebungstemperatur
LöslichkeitDMF, DMSO
Länge des Spacer-Arms4,4 Å
WasserlöslichNein
Chemische ReaktivitätAmin-Sulfhydryl
CleavableNein
Crosslinker-TypHeterobifunktional
FormatStandard
ProdukttypCrosslinker
AbstandshalterKurz (<10 Å)
Unit SizeEach
Inhalt und Lagerung
Nach Erhalt getrocknet bei 4 °C lagern.
Häufig gestellte Fragen (FAQ)
Can you provide the shelf-life for AMAS (N-α-maleimidoacet-oxysuccinimide ester)?
AMAS (N-α-maleimidoacet-oxysuccinimide ester is covered under our general 1-year warranty and is guaranteed to be fully functional for 12 months from the date of shipment, if stored as recommended. Please see section 8.1 of our Terms & Conditions of Sale (https://www.thermofisher.com/content/dam/LifeTech/Documents/PDFs/Terms-and-Conditions-of-Sale.pdf) for more details.
Dual binding mode of the nascent polypeptide-associated complex reveals a novel universal adapter site on the ribosome.
Authors:Pech M, Spreter T, Beckmann R, Beatrix B
Journal:J Biol Chem
PubMed ID:20410297
'Nascent polypeptide-associated complex (NAC) was identified in eukaryotes as the first cytosolic factor that contacts the nascent polypeptide chain emerging from the ribosome. NAC is present as a homodimer in archaea and as a highly conserved heterodimer in eukaryotes. Mutations in NAC cause severe embryonically lethal phenotypes in mice, Drosophila ... More
Analysis of RovA, a transcriptional regulator of Yersinia pseudotuberculosis virulence that acts through antirepression and direct transcriptional activation.
'The transcription factor RovA of Yersinia pseudotuberculosis and analogous proteins in other Enterobacteriaceae activate the expression of virulence genes that play a crucial role in stress adaptation and pathogenesis. In this study, we demonstrate that the RovA protein forms dimers independent of DNA binding, stimulates RNA polymerase, most likely via ... More
A central role for the T1 domain in voltage-gated potassium channel formation and function.
To interpret the recent atomic structures of the Kv (voltage-dependent potassium) channel T1 domain in a functional context, we must understand both how the T1 domain is integrated into the full-length functional channel protein and what functional roles the T1 domain governs. The T1 domain clearly plays a role in ... More
Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents.
Authors:Chen Z, Stokes DL, Rice WJ, Jones LR
Journal:J Biol Chem
PubMed ID:12972413
Heterobifunctional thiol to amine cross-linking agents were used to gain new insights on the dynamics and conformational factors governing the interaction between the cardiac Ca2+ pump (SERCA2a) and phospholamban (PLB). PLB is a small protein inhibitor of SERCA2a that reduces enzyme affinity for Ca2+ and thereby regulates cardiac contractility. We ... More